| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 985 |
| 1 | GUSELKUMAB | 779 |
| 2 | PEGINTERFERON BETA-1A | 468 |
| 3 | GOLIMUMAB | 413 |
| 4 | TOCILIZUMAB | 297 |
| 5 | ALBUTEROL SULFATE | 218 |
| 6 | INTERFERON BETA-1A | 201 |
| 7 | METHOTREXATE | 197 |
| 8 | USTEKINUMAB | 197 |
| 9 | PEGFILGRASTIM | 187 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, AND MAGNESIUM CHLORIDE | 1 | 0.0417 |
| 1 | PEGINTERFERON BETA-1A | 468 | 0.0357 |
| 2 | GOLIMUMAB | 413 | 0.0328 |
| 3 | ADALIMUMAB-ADBM | 8 | 0.0299 |
| 4 | GUSELKUMAB | 779 | 0.0204 |
| 5 | EXAGAMGLOGENE AUTOTEMCEL | 1 | 0.0200 |
| 6 | PEGFILGRASTIM | 187 | 0.0156 |
| 7 | BECLOMETHASONE DIPROPIONATE HFA | 40 | 0.0140 |
| 8 | TESTOSTERONE GEL, 1% | 3 | 0.0118 |
| 9 | ADALIMUMAB-AQVH | 1 | 0.0101 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 979 |
| 1 | Interferon beta [EPC] | 669 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 468 |
| 3 | Corticosteroid [EPC] | 328 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 297 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 239 |
| 6 | Interleukin-12 Antagonist [EPC] | 198 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 196 |
| 8 | Leukocyte Growth Factor [EPC] | 188 |
| 9 | Vitamin C [EPC] | 151 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 979 | 0.0093 |
| 1 | Interferon beta [EPC] | 669 | 0.0035 |
| 2 | Interferon alfa-2b [EPC] | 6 | 0.0032 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 4 | Provitamin D2 Compound [EPC] | 79 | 0.0027 |
| 5 | PCSK9 Inhibitor [EPC] | 58 | 0.0023 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 297 | 0.0021 |
| 7 | Interleukin-12 Antagonist [EPC] | 198 | 0.0019 |
| 8 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 9 | Leukocyte Growth Factor [EPC] | 188 | 0.0013 |